Matinas BioPharma Holdings Inc (NYSE American:MTNB)

Delayed Data
As of Aug 12
 -0.0008 / -0.09%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Matinas BioPharma Holdings Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +254.65% increase from the last price of 0.85.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Matinas BioPharma Holdings Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.08%
Growthannually 1.95%


Growthquarterly -28.30%
Growthannually 12,966.24%
Key to the earnings and sales forecast charts.